Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous System
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous System
Authors
Keywords
Atazanavir, Darunavir, Raltegravir, Maraviroc, Etravirine
Journal
CLINICAL PHARMACOKINETICS
Volume 53, Issue 10, Pages 891-906
Publisher
Springer Nature
Online
2014-09-08
DOI
10.1007/s40262-014-0171-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV protease inhibitor exposure predicts cerebral small vessel disease
- (2014) Virawudh Soontornniyomkij et al. AIDS
- The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV
- (2014) E. R. Hammond et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions
- (2014) Parvin Zakeri-Milani et al. Expert Opinion on Drug Metabolism & Toxicology
- Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy
- (2014) B. Mora-Peris et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations
- (2014) Cecile A. Delille et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients
- (2014) José L. Casado et al. JOURNAL OF NEUROVIROLOGY
- Prevalence and predictors of blood-brain barrier damage in the HAART era
- (2014) A. Calcagno et al. JOURNAL OF NEUROVIROLOGY
- Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
- (2014) Cagla Akay et al. JOURNAL OF NEUROVIROLOGY
- Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice
- (2014) Aedín M. Minogue et al. NEUROBIOLOGY OF AGING
- The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs
- (2014) Karolina M. Stępień et al. Pharmacological Reports
- Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
- (2014) Courtney V. Fletcher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Neuroimaging in HIV-Associated Neurocognitive Disorders
- (2014) Mary Masters et al. SEMINARS IN NEUROLOGY
- Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART
- (2013) Lucy J. Garvey et al. AIDS
- Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
- (2013) Matteo Vassallo et al. AIDS
- Increasing Extracellular Protein Concentration Reduces Intracellular Antiretroviral Drug Concentration and Antiviral Effect
- (2013) Lindsay B. Avery et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Incidence and Clinical Features of Cerebrovascular Disease Among HIV-Infected Adults in the Southeastern United States
- (2013) Michael J. Vinikoor et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration
- (2013) L. B. Avery et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia
- (2013) Nicoletta Ciccarelli et al. ANTIVIRAL THERAPY
- PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation
- (2013) Antonello Caruso et al. BIOCHEMICAL PHARMACOLOGY
- Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
- (2013) Ronald J. Ellis et al. CLINICAL INFECTIOUS DISEASES
- Monocyte/macrophages and their role in HIV neuropathogenesis
- (2013) Tricia H. Burdo et al. IMMUNOLOGICAL REVIEWS
- High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis
- (2013) A. Calcagno et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Etravirine in CSF is highly protein bound
- (2013) A. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predicting intestinal absorption of raltegravir using a population-based ADME simulation
- (2013) Darren M. Moss et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
- (2013) Aylin Yilmaz et al. Journal of Neuroinflammation
- High levels of divergent HIV-1 quasispecies in patients with neurological opportunistic infections in China
- (2013) Yulin Zhang et al. JOURNAL OF NEUROVIROLOGY
- Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect
- (2013) Birgit Grund et al. JOURNAL OF NEUROVIROLOGY
- CSF viral escape in a patient with HIV-associated neurocognitive disorder
- (2013) Michael N. Khoury et al. JOURNAL OF NEUROVIROLOGY
- Utility of CSF in translational neuroscience
- (2013) Elizabeth C. M. de Lange JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- HIV-associated neurocognitive disorder
- (2013) David B Clifford et al. LANCET INFECTIOUS DISEASES
- The Brain Entry of HIV-1 Protease Inhibitors Is Facilitated When Used in Combination
- (2013) Catia Marzolini et al. MOLECULAR PHARMACEUTICS
- Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter
- (2013) K. J. Kallianpur et al. NEUROLOGY
- Impact of pharmacogenetics on CNS side effects related to efavirenz
- (2013) Almudena Sánchez Martín et al. PHARMACOGENOMICS
- Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy
- (2013) Alan Winston et al. PLoS One
- The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
- (2013) Lachlan R. Gray et al. PLoS One
- HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients
- (2013) Victor G. Valcour et al. PLoS One
- Virological Efficacy in Cerebrospinal Fluid and Neurocognitive Status in Patients with Long-Term Monotherapy Based on Lopinavir/Ritonavir: An Exploratory Study
- (2013) José R. Santos et al. PLoS One
- Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
- (2013) Ignacio Pérez-Valero et al. PLoS One
- Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial
- (2013) Stefano Rusconi et al. PLoS One
- HIV and Neurocognitive Dysfunction
- (2013) Serena Spudich Current HIV/AIDS Reports
- HIV stroke risk: evidence and implications
- (2013) Elyse J. Singer et al. Therapeutic Advances in Chronic Disease
- Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration
- (2012) David Croteau et al. AIDS
- Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
- (2012) Michael J. Peluso et al. AIDS
- Determinants of darunavir cerebrospinal fluid concentrations
- (2012) Andrea Calcagno et al. AIDS
- Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
- (2012) Renaud A. Du Pasquier et al. AIDS
- Cognitive disorders in HIV-infected patients
- (2012) Fabrice Bonnet et al. AIDS
- Novel Method To Assess Antiretroviral Target Trough Concentrations UsingIn VitroSusceptibility Data
- (2012) Edward P. Acosta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340,In Vitro
- (2012) Eve-Irene Lepist et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV
- (2012) Cecilia M Shikuma et al. ANTIVIRAL THERAPY
- Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study
- (2012) K. Robertson et al. CLINICAL INFECTIOUS DISEASES
- CSF Penetration by Antiretroviral Drugs
- (2012) Christine Eisfeld et al. CNS DRUGS
- Alterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy
- (2012) Jaime H. Vera et al. HIV CLINICAL TRIALS
- Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score
- (2012) Y Kahouadji et al. HIV MEDICINE
- Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir
- (2012) Brookie M. Best et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid
- (2012) Alexia Cusini et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
- (2012) D. Croteau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier
- (2012) Shinsuke Nakagawa et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting
- (2012) Timothy Rawson et al. JOURNAL OF INFECTION
- Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
- (2012) Victor Valcour et al. JOURNAL OF INFECTIOUS DISEASES
- Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis
- (2012) Dionna W. Williams et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy
- (2012) Belinda Cruse et al. JOURNAL OF NEUROVIROLOGY
- Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy
- (2012) Torsak Bunupuradah et al. JOURNAL OF NEUROVIROLOGY
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage
- (2011) Andrea Calcagno et al. AIDS
- Recently Infiltrating MAC387+ Monocytes/Macrophages
- (2011) Caroline Soulas et al. AMERICAN JOURNAL OF PATHOLOGY
- Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
- (2011) Lucette A Cysique et al. BMC Neurology
- Current understanding of HIV-associated neurocognitive disorders pathogenesis
- (2011) Patrick Gannon et al. CURRENT OPINION IN NEUROLOGY
- Low Rates of Neurocognitive Impairment Are Observed in Neuro-Asymptomatic HIV-Infected Subjects on Effective Antiretroviral Therapy
- (2011) Lucy Garvey et al. HIV CLINICAL TRIALS
- Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)
- (2011) M Saumoy et al. HIV MEDICINE
- HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape
- (2011) R Bingham et al. INTERNATIONAL JOURNAL OF STD & AIDS
- CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study
- (2011) L. Garvey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Protease inhibitor monotherapy and the CNS: peace of mind?
- (2011) I. Perez-Valero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiretroviral drug treatment of CNS HIV-1 infection
- (2011) A. Yilmaz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens
- (2011) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus
- (2011) Isaac I. Bogoch et al. JOURNAL OF INFECTION
- Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
- (2011) Viktor Dahl et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression
- (2011) Lucette A. Cysique et al. JOURNAL OF NEUROVIROLOGY
- Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus Performance-Based Assessment of Everyday Functioning
- (2011) K. Blackstone et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
- (2011) Brian Giunta et al. Molecular Brain
- Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms
- (2010) Giovanna Melica et al. AIDS
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1
- (2010) D. Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid
- (2010) S. F. L. van Lelyveld et al. CLINICAL INFECTIOUS DISEASES
- Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study
- (2010) Alan Winston et al. CLINICAL INFECTIOUS DISEASES
- Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
- (2010) Nina Friis-Møller et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Maraviroc Concentrations in Cerebrospinal Fluid in HIV-Infected Patients
- (2010) Juan Manuel Tiraboschi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
- (2010) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
- (2010) B. M. Best et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
- (2010) Arvid Edén et al. JOURNAL OF INFECTIOUS DISEASES
- Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
- (2010) K. R. Robertson et al. NEUROLOGY
- HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
- (2010) Ruben C. Hartkoorn et al. Pharmacogenetics and Genomics
- Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients
- (2009) Aylin Yilmaz et al. AIDS
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected Individuals
- (2009) Aylin Yilmaz et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
- (2009) Robert DiCenzo et al. ANNALS OF PHARMACOTHERAPY
- The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
- (2009) Lavanya Varatharajan et al. ANTIVIRAL RESEARCH
- Imaging the Function of P-Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications
- (2009) P Kannan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches
- (2009) Marcus Kaul CURRENT OPINION IN NEUROLOGY
- Blood-brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edema
- (2009) Nicola Marchi et al. EPILEPSIA
- Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma
- (2009) Cathia Soulié et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders
- (2009) Valerio Tozzi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
- (2009) L. A. Cysique et al. NEUROLOGY
- Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
- (2009) Aylin Yilmaz et al. PLoS One
- Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1–Associated Dementia
- (2009) Gretja Schnell et al. PLoS Pathogens
- Low atazanavir concentrations in cerebrospinal fluid
- (2008) Brookie M Best et al. AIDS
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid
- (2008) X. Liu et al. DRUG METABOLISM AND DISPOSITION
- Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection
- (2008) Lin Shen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started